Article Information
History
- February 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Junna Oba1,2,
- Hiroaki Taniguchi1,3,4,*,
- Masae Sato1,
- Masaki Takanashi5,
- Moe Yokemura5,
- Yasunori Sato6 and
- Hiroshi Nishihara1,3,4
- 1Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
- 2Department of Extended Intelligence for Medicine, The Ishii-Ishibashi Laboratory, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
- 3Research and Development Center for Precision Medicine, University of Tsukuba, Innovation Medical Research Institute, 1-2 Kasuga, Tsukuba-shi, Ibaraki 305-8550, Japan
- 4Keio University Hospital Clinical and Translational Research Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
- 5LSI Medience Corporation Central Laboratory Center, 3-30-1 Shimura, Itabashi-ku, Tokyo 174-8555, Japan
- 6Department of Preventive Medicine and Public Health, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
- ↵*Correspondence: h-tani{at}keio.jp; Tel. +81-3-5315-4375
Posted February 02, 2022.
SARS-CoV-2 RT-qPCR testing of pooled saliva samples: a case study of 824 asymptomatic individuals and a questionnaire survey in Japan
